| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |